• Ibrutinib (PCI-32765): A BTK Assay Design Guide

  2026-08-13

  Ibrutinib (PCI-32765) is a covalent BTK inhibitor for mechanistic studies of B-cell receptor signaling, CLL biology, and immune-cell activation. This guide moves beyond target description to explain how genotype-aware controls, orthogonal readouts, and formulation discipline improve experimental interpretation.

• Eudragit-Coated LNPs for Oral RNA Delivery

  2026-08-12

  Haque, Shrestha, and Mattheolabakis developed a pH-responsive Eudragit S 100 coating strategy intended to protect lipid nanoparticles and their RNA cargo during gastrointestinal transit. The study shows that coated nanoparticles can regain a nanoscale size at alkaline pH, protect nucleic acids in simulated gastric fluid, and retain in vitro transfection capacity, while also highlighting the need for in vivo validation.

• Sodium Oxamate: From Glycolysis to Lactylation

  2026-08-12

  Sodium Oxamate is best known as a competitive LDH-A inhibitor for cancer metabolism research, but emerging neurobiology shows why lactate suppression must be interpreted in cellular and epigenetic context. This thought-leadership article connects glycolytic flux, H3K18 lactylation, microglial function, and translational study design while outlining how to use Sodium Oxamate as a rigorous metabolic perturbation tool.

• Spermine tetrahydrochloride: Applied Workflows

  2026-08-11

  Spermine tetrahydrochloride is a charge-active polyamine that connects membrane protection, protein crystallization, and polymer nanoparticle assembly in one adaptable reagent. This guide translates published protoplast methods into practical assay workflows while defining where protein, polymer, and NMDA receptor applications require separate validation.

• Lactobacillus acidophilus–UDCA in Ulcerative Colitis

  2026-08-10

  Deng et al. show that Lactobacillus acidophilus can ameliorate experimental ulcerative colitis partly through the microbial metabolite ursodeoxycholic acid. The study links this microbiota–metabolite axis to coordinated Treg promotion, M1 macrophage suppression, and RapGap/PI3K-AKT/NF-κB signaling, providing a mechanistic framework for probiotic research.

• Perospirone: Receptor and Kv1.5 Research Workflow

  2026-08-09

  Perospirone (SM-9018 free base) supports a two-tier research strategy: receptor-focused neuropharmacology at nanomolar concentrations and vascular Kv-channel profiling at micromolar concentrations. This workflow helps researchers separate intended serotonergic and dopaminergic effects from a newly characterized Kv1.5-related off-target response.

• 5-Azacytidine Workflows for DNA Demethylation

  2026-08-08

  Build reproducible 5-Azacytidine assays for gene reactivation, leukemia-cell responses, and methylation-driven stem-cell phenotypes. This practical guide combines dose–time optimization with the UHRF1–5-mC–TGM2 framework to distinguish epigenetic effects from nonspecific cytotoxicity.

• Myriocin as a Causal Probe of Lipid-Driven Aging

  2026-08-07

  Myriocin is a potent serine palmitoyltransferase inhibitor that can help test whether sphingolipid metabolism contributes to mitochondrial aging phenotypes. This article connects a recent Ginkgo biloba–yeast longevity study with a rigorous perturbation framework for interpreting lipid, mitochondrial, and cell-survival data.

• Cholesterol’s Strategic Role in mRNA-LNP Cancer Therapeutics

  2026-08-07

  Explore how cholesterol, the principal sterol, underpins the next generation of lipid nanoparticle (LNP) systems for mRNA-based localized cancer therapies. This thought-leadership article blends mechanistic insight with translational strategy, highlighting key findings from recent bladder cancer research and offering actionable guidance for researchers optimizing membrane fluidity, lipid metabolism assays, and clinical protocol design. Discover how high-purity cholesterol from APExBIO advances both fundamental and applied research beyond typical product narratives.

• EZ Cap™ Firefly Luciferase mRNA: Optimizing Reporter Assays

  2026-08-06

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers unparalleled stability and translation efficiency for gene regulation and in vivo imaging workflows. Its design enables robust signal output across a range of mRNA delivery systems, providing researchers with a versatile, troubleshoot-ready tool for sensitive bioluminescent assays.

• Norovirus Exploits NINJ1 for Selective Viral Protein Secreti

  2026-08-06

  Song et al. reveal that murine norovirus co-opts the host cell death effector NINJ1 to mediate the selective secretion of its NS1 protein via caspase-3–dependent cleavage. This work uncovers a previously unrecognized intersection between programmed cell death and viral immune evasion, with implications for apoptosis research and antiviral strategies.

• Berberine Hydrochloride: Beyond the Gut–Bone Axis in Metabol

  2026-08-05

  Explore how Berberine hydrochloride advances metabolic and bone research through unique mechanisms, including AMPK activation and ferroptosis inhibition. This article offers fresh insights for scientists seeking rigorous, protocol-ready guidance on Berberine hydrochloride applications.

• Taxus chinensis Fruit Extract Mitigates Neuroinflammation vi

  2026-08-05

  A recent study demonstrates that Taxus chinensis fruit extract (TCFE) alleviates aging behaviors and neuroinflammation in mice by inhibiting microglial activation through the TLR4/NF-κB/NLRP3 pathway. These findings advance understanding of plant-derived modulators in inflammatory signaling and provide mechanistic insight for translational research in neurodegenerative and age-related diseases.

• Streamlining Spiramycin Derivative Production via 3-O-Acyltr

  2026-08-04

  This study reports the construction of a genetically engineered Streptomyces spiramyceticus strain that exclusively produces 400-isovalerylspiramycin I, a simplified macrolide antibiotic derivative. By inactivating the 3-O-acyltransferase gene, the researchers reduced product heterogeneity, offering a cleaner platform for antibiotic research and potential clinical manufacturing.

• GPR30 in Spinal CCK+ Neurons Regulates Neuropathic Pain Circ

  2026-08-04

  This study reveals that GPR30, a membrane estrogen receptor, is upregulated in spinal cholecystokinin-positive (CCK+) neurons following nerve injury and is essential for the enhancement of excitatory synaptic transmission underlying neuropathic pain. By inhibiting GPR30, the research demonstrates reversal of pain behaviors in mice, identifying a critical target for understanding and potentially treating neuropathic pain.

448 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page